Key Insights
The Latin America melanoma diagnostics and therapeutics market is experiencing robust growth, projected to reach a substantial size by 2033. A compound annual growth rate (CAGR) of 13.80% from 2019 to 2024 indicates significant market expansion driven by several factors. Rising melanoma incidence rates across the region, fueled by increasing UV radiation exposure and changing lifestyles, are a primary driver. Advancements in diagnostic technologies, such as improved imaging techniques and molecular diagnostics like gene expression profiling, are enabling earlier and more accurate detection, leading to improved patient outcomes and market growth. Furthermore, the introduction of innovative targeted therapies and immunotherapies offers more effective treatment options, contributing to the market's expansion. The market is segmented by product type, encompassing diagnostics and biopsy devices along with therapeutics. Key players like DermTech, Novartis, Amgen, Merck, Abbott, Roche, bioMérieux, and others are actively contributing to market growth through research and development, strategic partnerships, and product launches. Within Latin America, Brazil, Argentina, and Mexico are expected to be the largest markets, owing to their higher population density and healthcare infrastructure. However, challenges remain, including limited access to advanced diagnostics and treatment in some regions, and high costs associated with innovative therapies which can restrict affordability for a segment of the population. Nevertheless, the overall market outlook remains positive, driven by continuous technological advancements, increasing awareness about melanoma, and growing government initiatives supporting cancer care.
The market's future growth trajectory is expected to be influenced by factors such as the increasing adoption of teledermatology for early detection, the development of personalized medicine approaches tailored to specific melanoma subtypes, and the expansion of clinical trials evaluating novel treatment modalities. The rising prevalence of skin cancer in the region, coupled with an increasing awareness among the population of its dangers, is likely to result in a growing demand for timely and effective diagnostics and therapeutic solutions. The substantial investment in research and development undertaken by various pharmaceutical companies within the region should contribute further to market expansion over the forecast period.

Latin America Melanoma Diagnostics and Therapeutics Market: A Comprehensive Report (2019-2033)
This insightful report provides a detailed analysis of the Latin America Melanoma Diagnostics and Therapeutics Market, offering a comprehensive overview of market size, growth drivers, challenges, and future opportunities. Covering the period from 2019 to 2033, with a focus on 2025 as the base and estimated year, this report is an essential resource for stakeholders seeking to understand and capitalize on this dynamic market. The market is projected to reach xx Million by 2033, exhibiting a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033).
Latin America Melanoma Diagnostics and Therapeutics Market Market Composition & Trends
This section delves into the competitive landscape, analyzing market concentration, innovation drivers, regulatory frameworks, substitute products, end-user profiles, and mergers & acquisitions (M&A) activities within the Latin American melanoma diagnostics and therapeutics market. The market exhibits a moderately concentrated structure, with key players holding significant market share. However, the entry of new players and technological advancements are expected to increase competition in the coming years.
Market Share Distribution (2024):
- Abbott Diagnostics: xx%
- Roche: xx%
- Novartis AG: xx%
- Others: xx%
Innovation Catalysts: The market is driven by continuous technological advancements in diagnostic tools (e.g., advanced imaging techniques, molecular diagnostics) and therapeutic options (e.g., targeted therapies, immunotherapies). Furthermore, increasing awareness and early detection initiatives are fueling market growth.
Regulatory Landscape: Regulatory approvals and reimbursement policies significantly impact market access and adoption of new technologies and therapies. Variations in regulatory frameworks across different Latin American countries present both opportunities and challenges.
Substitute Products: The availability of alternative treatments and diagnostic methods influences the market dynamics. The report analyzes the impact of substitute products on market growth.
End-User Profiles: The report profiles key end-users, including hospitals, clinics, dermatology practices, and research institutions, analyzing their needs and preferences.
M&A Activities: The report analyzes recent M&A activities, including deal values and their impact on market consolidation. While precise deal values are unavailable, the report observes a moderate level of M&A activity, signifying industry consolidation.

Latin America Melanoma Diagnostics and Therapeutics Market Industry Evolution
This section provides a detailed analysis of the Latin America melanoma diagnostics and therapeutics market's evolutionary trajectory, encompassing growth trajectories, technological advancements, and evolving consumer demands. The market experienced significant growth between 2019 and 2024, driven by factors like increased melanoma incidence, rising healthcare expenditure, and improved access to advanced diagnostic and therapeutic technologies. Technological advancements such as liquid biopsies and next-generation sequencing are transforming diagnostics, leading to earlier and more precise detection. The market is also witnessing the emergence of personalized medicine approaches, allowing for tailored treatments based on individual patient characteristics. Furthermore, increasing patient awareness about melanoma and its treatment options is driving demand for advanced diagnostic and therapeutic solutions. The market's growth is expected to accelerate in the forecast period (2025-2033) due to a combination of factors, including increasing government initiatives for cancer control programs and the introduction of novel therapies. Growth rates for diagnostics and therapeutics will be analyzed separately, taking into account regional disparities in access to healthcare.
Leading Regions, Countries, or Segments in Latin America Melanoma Diagnostics and Therapeutics Market
This section identifies the dominant regions, countries, and segments within the Latin America melanoma diagnostics and therapeutics market.
Dominant Segment: The therapeutics segment currently holds the largest market share, primarily driven by the increasing demand for advanced therapies like immunotherapy and targeted therapy. However, the diagnostics segment is expected to witness robust growth due to innovations in early detection technologies.
Key Drivers (By Region/Country):
- Brazil: High melanoma incidence, growing healthcare infrastructure, and increasing government initiatives for cancer control programs.
- Mexico: Rising healthcare expenditure and increased adoption of advanced diagnostic and therapeutic technologies.
- Argentina: Growing awareness of melanoma and its treatment options.
Dominance Factors: The dominance of specific regions and segments is influenced by various factors, including melanoma incidence rates, healthcare infrastructure, regulatory environments, economic conditions, and access to advanced technologies. The report offers a granular analysis of these dominance factors for each region and segment.
Latin America Melanoma Diagnostics and Therapeutics Market Product Innovations
Recent innovations in melanoma diagnostics and therapeutics include advanced imaging techniques offering improved visualization of melanomas, liquid biopsy technologies enabling early detection through minimally invasive procedures, and targeted therapies offering improved efficacy and reduced side effects compared to traditional treatments. These innovations are characterized by improved sensitivity, specificity, and patient outcomes.
Propelling Factors for Latin America Melanoma Diagnostics and Therapeutics Market Growth
Several factors are driving market growth, including technological advancements in diagnostics and therapeutics, increasing awareness about melanoma and its prevention, rising healthcare expenditure, and supportive government initiatives promoting cancer control programs. Government funding for research and development in oncology is also boosting innovation and market expansion.
Obstacles in the Latin America Melanoma Diagnostics and Therapeutics Market Market
Challenges include high treatment costs limiting access to advanced therapies, variations in regulatory frameworks across different countries, and the potential for supply chain disruptions affecting the availability of diagnostic and therapeutic products. Furthermore, the uneven distribution of healthcare resources across the region creates disparities in access to advanced treatments and diagnosis.
Future Opportunities in Latin America Melanoma Diagnostics and Therapeutics Market
Future opportunities encompass the development and adoption of personalized medicine approaches, the expansion of telemedicine for remote diagnosis and monitoring, and the exploration of novel therapeutic strategies, such as oncolytic viruses and CAR T-cell therapy. These opportunities are anticipated to drive further market expansion.
Major Players in the Latin America Melanoma Diagnostics and Therapeutics Market Ecosystem
- DermTech
- Novartis AG
- Amgen Inc
- Merck & Co Inc
- Abbott Diagnostics
- F Hoffman-La Roche Ltd
- bioMerieux SA
- Dermlite
- GlaxoSmithKline PLC
- Pfizer Inc
Key Developments in Latin America Melanoma Diagnostics and Therapeutics Market Industry
- November 2022: Medison Pharma expands its agreement with Immunocore Holdings plc to include South and Central America and the Caribbean, signifying increased access to novel immunotherapies for melanoma.
- April 2021: The Melanoma Research Alliance supports a multinational research collaboration involving scientists from Mexico, Brazil, and the UK, fostering innovation in melanoma research.
Strategic Latin America Melanoma Diagnostics and Therapeutics Market Forecast
The Latin America melanoma diagnostics and therapeutics market is poised for significant growth, driven by the factors mentioned above. The market's future potential is substantial, with ongoing technological advancements, expanding healthcare infrastructure, and increasing government support expected to further drive market expansion. The market is expected to continue its growth trajectory, presenting lucrative opportunities for both established and emerging players.
Latin America Melanoma Diagnostics and Therapeutics Market Segmentation
-
1. Product Type
-
1.1. Diagnostics
- 1.1.1. Dermatoscopy Devices
- 1.1.2. Biopsy Devices
-
1.2. Therapeutics
- 1.2.1. Chemotherapy
- 1.2.2. Targeted Therapy
- 1.2.3. Immune Therapy
-
1.1. Diagnostics
-
2. Geography
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Mexico
- 2.4. Rest of Latin America
Latin America Melanoma Diagnostics and Therapeutics Market Segmentation By Geography
- 1. Brazil
- 2. Argentina
- 3. Mexico
- 4. Rest of Latin America

Latin America Melanoma Diagnostics and Therapeutics Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 13.80% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Incidences of Melanoma Cases; Advancements in Diagnosis and Treatments and Rising Government Initiatives
- 3.3. Market Restrains
- 3.3.1. Lack of Awareness and High Cost Associated With the Therapy
- 3.4. Market Trends
- 3.4.1. Biological Therapy is Expected to Witness High Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 5.1.1. Diagnostics
- 5.1.1.1. Dermatoscopy Devices
- 5.1.1.2. Biopsy Devices
- 5.1.2. Therapeutics
- 5.1.2.1. Chemotherapy
- 5.1.2.2. Targeted Therapy
- 5.1.2.3. Immune Therapy
- 5.1.1. Diagnostics
- 5.2. Market Analysis, Insights and Forecast - by Geography
- 5.2.1. Brazil
- 5.2.2. Argentina
- 5.2.3. Mexico
- 5.2.4. Rest of Latin America
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Brazil
- 5.3.2. Argentina
- 5.3.3. Mexico
- 5.3.4. Rest of Latin America
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 6. Brazil Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Product Type
- 6.1.1. Diagnostics
- 6.1.1.1. Dermatoscopy Devices
- 6.1.1.2. Biopsy Devices
- 6.1.2. Therapeutics
- 6.1.2.1. Chemotherapy
- 6.1.2.2. Targeted Therapy
- 6.1.2.3. Immune Therapy
- 6.1.1. Diagnostics
- 6.2. Market Analysis, Insights and Forecast - by Geography
- 6.2.1. Brazil
- 6.2.2. Argentina
- 6.2.3. Mexico
- 6.2.4. Rest of Latin America
- 6.1. Market Analysis, Insights and Forecast - by Product Type
- 7. Argentina Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Product Type
- 7.1.1. Diagnostics
- 7.1.1.1. Dermatoscopy Devices
- 7.1.1.2. Biopsy Devices
- 7.1.2. Therapeutics
- 7.1.2.1. Chemotherapy
- 7.1.2.2. Targeted Therapy
- 7.1.2.3. Immune Therapy
- 7.1.1. Diagnostics
- 7.2. Market Analysis, Insights and Forecast - by Geography
- 7.2.1. Brazil
- 7.2.2. Argentina
- 7.2.3. Mexico
- 7.2.4. Rest of Latin America
- 7.1. Market Analysis, Insights and Forecast - by Product Type
- 8. Mexico Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Product Type
- 8.1.1. Diagnostics
- 8.1.1.1. Dermatoscopy Devices
- 8.1.1.2. Biopsy Devices
- 8.1.2. Therapeutics
- 8.1.2.1. Chemotherapy
- 8.1.2.2. Targeted Therapy
- 8.1.2.3. Immune Therapy
- 8.1.1. Diagnostics
- 8.2. Market Analysis, Insights and Forecast - by Geography
- 8.2.1. Brazil
- 8.2.2. Argentina
- 8.2.3. Mexico
- 8.2.4. Rest of Latin America
- 8.1. Market Analysis, Insights and Forecast - by Product Type
- 9. Rest of Latin America Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Product Type
- 9.1.1. Diagnostics
- 9.1.1.1. Dermatoscopy Devices
- 9.1.1.2. Biopsy Devices
- 9.1.2. Therapeutics
- 9.1.2.1. Chemotherapy
- 9.1.2.2. Targeted Therapy
- 9.1.2.3. Immune Therapy
- 9.1.1. Diagnostics
- 9.2. Market Analysis, Insights and Forecast - by Geography
- 9.2.1. Brazil
- 9.2.2. Argentina
- 9.2.3. Mexico
- 9.2.4. Rest of Latin America
- 9.1. Market Analysis, Insights and Forecast - by Product Type
- 10. Brazil Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 11. Argentina Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 12. Mexico Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 13. Peru Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 14. Chile Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 15. Rest of Latin America Latin America Melanoma Diagnostics and Therapeutics Market Analysis, Insights and Forecast, 2019-2031
- 16. Competitive Analysis
- 16.1. Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 DermTech
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Novartis AG
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Amgen Inc
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Merck & Co Inc
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Abbott Diagnostics
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 F Hoffman-La Roche Ltd
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 bioMerieux SA
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Dermlite*List Not Exhaustive
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 GlaxoSmithKline PLC
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Pfizer Inc
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.1 DermTech
List of Figures
- Figure 1: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Latin America Melanoma Diagnostics and Therapeutics Market Share (%) by Company 2024
List of Tables
- Table 1: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 3: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 4: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Brazil Latin America Melanoma Diagnostics and Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: Argentina Latin America Melanoma Diagnostics and Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Mexico Latin America Melanoma Diagnostics and Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Peru Latin America Melanoma Diagnostics and Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Chile Latin America Melanoma Diagnostics and Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Rest of Latin America Latin America Melanoma Diagnostics and Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 13: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 14: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 15: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 16: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 17: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 19: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 20: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 21: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 22: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 23: Latin America Melanoma Diagnostics and Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Latin America Melanoma Diagnostics and Therapeutics Market?
The projected CAGR is approximately 13.80%.
2. Which companies are prominent players in the Latin America Melanoma Diagnostics and Therapeutics Market?
Key companies in the market include DermTech, Novartis AG, Amgen Inc, Merck & Co Inc, Abbott Diagnostics, F Hoffman-La Roche Ltd, bioMerieux SA, Dermlite*List Not Exhaustive, GlaxoSmithKline PLC, Pfizer Inc.
3. What are the main segments of the Latin America Melanoma Diagnostics and Therapeutics Market?
The market segments include Product Type, Geography.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Incidences of Melanoma Cases; Advancements in Diagnosis and Treatments and Rising Government Initiatives.
6. What are the notable trends driving market growth?
Biological Therapy is Expected to Witness High Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Lack of Awareness and High Cost Associated With the Therapy.
8. Can you provide examples of recent developments in the market?
In November 2022, Medison Pharma announced the addition of South and Central America and the Caribbean markets, to its multi-territorial agreement with Immunocore Holdings plc, a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer like melanoma, infection and autoimmune disease.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Latin America Melanoma Diagnostics and Therapeutics Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Latin America Melanoma Diagnostics and Therapeutics Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Latin America Melanoma Diagnostics and Therapeutics Market?
To stay informed about further developments, trends, and reports in the Latin America Melanoma Diagnostics and Therapeutics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence